Review · Volume 7, Issue 2 · pp. 41–46
Compensation to clinical trial participants in India: A gap analysis
Mohd Urooj1, Gulam Mohammed Husain1, Mohammad Ahmed Khan1, Munawwar Husain Kazmi1
- 1Department of Pharmacology, Central Research Institute of Unani Medicine, Under CCRUM, Ministry of AYUSH Government of India, Hyderabad, Telangana, INDIA.
Abstract
The recent amendments notified by the Government of India, for conducting clinical trial, is greatly appreciable as promoting safety and well‑being of human subjects. These rules clearly state that medical management of injuries in clinical trials is mandatory, and clinical trial‑related injury or death needs to be compensated over and above the medical management. These rules need to be reconsidered for simplification and better understanding of issues regarding compensation. There is a need of clarity at some points which should be discussed with all stakeholders for better understanding of current regulations. In our view, attention must also be given to academic investigators, during discussion to promote availability of cost‑effective treatment in India.
Keywords: Adverse event; ethics; injury/death
The full text of this article is available as a PDF. Open the PDF.